𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor lymphangiogenesis in head and neck squamous cell carcinoma : A morphometric study with clinical correlations

✍ Scribed by Alessandro Franchi; Oreste Gallo; Daniela Massi; Gianna Baroni; Marco Santucci


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
159 KB
Volume
101
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Tumor metastasis to regional lymph nodes via the lymphatic system represents the first step of dissemination in head and neck squamous cell carcinoma (HNSCC) and serves as a major prognostic indicator for disease progression and as a guide for therapeutic strategies. In the current study, the authors investigated whether tumor lymphangiogenesis may be related to the risk of lymph node metastasis and to clinical outcome in patients with HNSCC.

METHODS

Immunostaining for the lymphatic marker D2‐40 was used, and lymphangiogenesis was quantified within the tumor and in the peritumoral area in 52 HNSCC specimens using computer‐assisted morphometric analysis.

RESULTS

Lymphatic vessels were found to be significantly more numerous and larger in the peritumoral area compared with within the tumor, and the number and relative area of intratumoral and peritumoral lymphatics was significantly higher in HNSCC cases with lymph node metastasis. Multivariate analysis demonstrated that high peritumoral lymphangiogenesis (above the median value) was associated with an increased risk of developing lymph node metastasis. No correlation was found between tumor lymphangiogenesis and the disease‐free or overall survival in the current series.

CONCLUSIONS

The results indicate that peritumoral lymphangiogenesis may be an indicator of the risk of lymph node metastasis in patients with HNSCC. Cancer 2004. Β© 2004 American Cancer Society.


πŸ“œ SIMILAR VOLUMES


Tumor lymphangiogenesis correlates with
✍ Mayumi Miyahara; Jun-ichi Tanuma; Kazumasa Sugihara; Ichiro Semba πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 370 KB

## Abstract ## BACKGROUND. Lymphatic vessel density (LVD) and microvessel density (MVD) are important parameters for assessing the malignant potential of tumors and patient survival. In this report, the authors defined LVD as the density of D2‐40‐positive lymphatic vessels and MVD as the density o

P53 mutation correlates with cisplatin s
✍ Carol R. Bradford; Shaobo Zhu; Haruko Ogawa; Tetsuya Ogawa; Matthew Ubell; Ajita πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 2 views

## Background: A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did

Inducible nitric oxide synthase: Correla
✍ Peter A. Brennan; Simon Dennis; David Poller; Marisol Quintero; Roberto Puxeddu; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 266 KB πŸ‘ 2 views

## Abstract ## Background Extracapsular nodal spread is a major prognostic indicator in head and neck cancer. Nitric oxide (NO), primarily produced by the enzyme inducible NO synthase (iNOS), has a large number of actions in cancer biology, but no studies have investigated its possible role in ext

Tumor microenvironment in head and neck
✍ Ilse J. Hoogsteen; Henri A. M. Marres; Johan Bussink; Albert J. van der Kogel; J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 340 KB πŸ‘ 2 views

## Abstract ## Background. Hypoxia and tumor cell proliferation are important factors determining the treatment response of squamous cell carcinomas of the head and neck. Successful approaches have been developed to counteract these resistance mechanisms although usually at the cost of increased s

Radioimmunotherapy in patients with head
✍ David R. Colnot; Jasper J. Quak; Jan C. Roos; Remco de Bree; Abraham J. Wilhelm; πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 2 views

## Abstract ## Background Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), local and distant failure rates remain high. An effective adjuvant therapy is required for these patients. Among novel approaches is radioimmunotherapy, i